Estrogen Avoidance Results in Unnecessary Deaths
By HospiMedica International staff writers Posted on 31 Jul 2013 |
A new study calculates that rejecting estrogen-only hormone replacement therapy (HRT) has resulted in the early deaths of nearly 50,000 women.
Researchers at Yale University (New Haven, CT, USA) and Universita di Firenze (Florence, Italy) conducted a study that examined the effect of estrogen avoidance on mortality rates among hysterectomized women. To do so, the researchers derived a formula to relate the excess mortality in hysterectomized women aged 50 to 59 years assigned to placebo in the Women’s Health Initiative (WHI) randomized controlled trial to the entire population of comparable women in the United States, incorporating the decline in estrogen use observed between 2002 and 2011.
The results showed that over the 10-year span, a minimum of 18,601 and as many as 91,610 postmenopausal women aged 50 to 59 years died prematurely due to the avoidance of estrogen HRT. When the researchers examined mortality rate data in a separate group of women than those followed in the WHI 2002 trial, their analysis further estimated that between 40,292 and 48,835 women died prematurely during the study period. The study was published online ahead of print on July 18, 2013, in the American Journal of Public Health.
“Distortion of details can prove to be nothing less than lethal. What has happened is an avoidance of use of estrogen not because of the findings, but because of the way they were communicated and understood,” concluded lead author Emeritus Prof. Philip Sarrel, MD, of Yale, and colleagues. “None of those women lived to be 70 years old. They were all women aged 50-59 who would have used estrogen but did not use it because of unfounded fears.”
Prior to 2002, 90% of US women who had had hysterectomies used HRT estrogen therapy for around five years. But those numbers have plummeted since the WHI cut short its Estrogen Plus Progestin Trial in 2002, when study results revealed that women who took the two-hormone therapy suffered adverse effects and higher mortality. Today, less than a third receive HRT, even though ongoing studies by the WHI in 2004 and 2011 have shown that women took estrogen alone actually had a decreased risk of early death compared to women taking a placebo, mostly due to reduced incidence of heart disease.
Related Links:
Yale University
Universita di Firenze
Researchers at Yale University (New Haven, CT, USA) and Universita di Firenze (Florence, Italy) conducted a study that examined the effect of estrogen avoidance on mortality rates among hysterectomized women. To do so, the researchers derived a formula to relate the excess mortality in hysterectomized women aged 50 to 59 years assigned to placebo in the Women’s Health Initiative (WHI) randomized controlled trial to the entire population of comparable women in the United States, incorporating the decline in estrogen use observed between 2002 and 2011.
The results showed that over the 10-year span, a minimum of 18,601 and as many as 91,610 postmenopausal women aged 50 to 59 years died prematurely due to the avoidance of estrogen HRT. When the researchers examined mortality rate data in a separate group of women than those followed in the WHI 2002 trial, their analysis further estimated that between 40,292 and 48,835 women died prematurely during the study period. The study was published online ahead of print on July 18, 2013, in the American Journal of Public Health.
“Distortion of details can prove to be nothing less than lethal. What has happened is an avoidance of use of estrogen not because of the findings, but because of the way they were communicated and understood,” concluded lead author Emeritus Prof. Philip Sarrel, MD, of Yale, and colleagues. “None of those women lived to be 70 years old. They were all women aged 50-59 who would have used estrogen but did not use it because of unfounded fears.”
Prior to 2002, 90% of US women who had had hysterectomies used HRT estrogen therapy for around five years. But those numbers have plummeted since the WHI cut short its Estrogen Plus Progestin Trial in 2002, when study results revealed that women who took the two-hormone therapy suffered adverse effects and higher mortality. Today, less than a third receive HRT, even though ongoing studies by the WHI in 2004 and 2011 have shown that women took estrogen alone actually had a decreased risk of early death compared to women taking a placebo, mostly due to reduced incidence of heart disease.
Related Links:
Yale University
Universita di Firenze
Latest Patient Care News
- Portable Biosensor Platform to Reduce Hospital-Acquired Infections
- First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read moreSurgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more